New in CME courses – Optimizing Glycemic Control: A Continuing Quality Improvement Program for Primary Care

Topic: Endocrinology Target Audience: Primary Care Clinicians The Family Medicine Associates wrap up their Quality Improvement program on the management of Type 2 Diabetes. By the end of the course, participants will be able to: Outline the benefits, indications, and role of continuous Read More

New in CME Courses – Optimizing Control in T2D: Part 2 in a Quality Improvement Program for Primary Care

Target audience: Primary Care Clinicians The Family Medicine Associates are back for the second round of their Quality Improvement program! In this second activity of the curriculum, you will be re-introduced to Family Medicine Associates, a "virtual" family medicine clinic that is initiating a QI Read More

NEW in CME Courses: Improving Healthcare Delivery in Immuno-Oncology: A Global Quality Improvement Initiative-Module 1

 Expand your knowledge of quality improvement tools and strategies Target Audience: Oncologists; Hematologists; Hematologist/Oncologists   The introduction of immune checkpoint inhibitors has resulted in a paradigm shift for the management of many historically difficult-to-treat Read More

New in CME Courses: Achieving Glycemic Control in Type 2 Diabetes – A Quality Improvement Program for Primary Care​

  Target audience: Primary Care Clinicians Explore a Virtual QI to Improve Diabetes Care in Your Practice!​ Type 2 diabetes (T2D) is often inadequately managed. Many patients with T2D struggle to meet glycemic targets and use of advanced therapies like insulin may be delayed. Primary Read More

New in CME Courses: Optimizing Immunization in IBD: A Quality Improvement Curriculum

Target audience: Gastroenterologists, gastroenterology fellows, gastroenterology NPs/PAs, gastroenterology nurses, and other healthcare providers who manage patients with IBD, including primary care/internal medicine clinicians Improve the Quality of Preventive Care in IBD Variation in the Read More

New in CME Courses: Optimizing Outcomes in Distributive Shock: A Self-assessment Program​

Target audience: Critical care teams of physicians; nurses; nurse practitioners; physician assistants; pharmacists, respiratory care therapists, dieticians and physical therapists; and other clinicians involved in the evaluation and management of patients with distributive shock. Refractory Read More

New in CME Courses: Non-Small Cell Lung Cancer: Optimizing Systemic Therapy Options Beyond the 1st Line

Target audience:  Oncologists, oncology nurses, pathologists, radiologists, pharmacists, and other healthcare practitioners who care for patients with lung cancer. Disease Progression After First Line Therapy Patients refractory to first-line therapy have a particularly poor prognosis and present Read More

New in CME courses: Experts in the Hot Seat: Navigating PCSK9 Inhibitor Prescribing in Persistent Elevated LDL-C

Target audience:  Lipidologists, endocrinologists, cardiologists, nurse practitioners, physician assistants, registered dietitians, advanced practice registered nurses, registered nurses, and pharmacists who are members of the NLA, as well as a national cohort of providers who manage patients with Read More

New in CME courses: Targeting Molecular Mechanisms in Patients with Metastatic Breast Cancer: Inhibiting Estrogen Receptor-Induced Proliferation

Target audience:  Oncologists, surgeons, ONS nurses, and other healthcare providers involved in the treatment of patients with breast cancer. The complexity of breast cancer continues to be revealed Ten-year breast-cancer (BC) mortality rates are reduced by a third with hormone therapy, meaning Read More

New in CME Courses: Case Challenges in the Use of Insulin in Type 2 Diabetes

Target audience:  Endocrinologists, primary care physicians, and other members of the care team involved in the management of patients with T2DM, including endocrinology and primary care nurse practitioners (NPs), physician assistants (PAs), and nurses. Type 2 diabetes (T2DM) is a complex, Read More